
Investors 1
Date | Name | Website |
- | Cenova Cap... | cenova.com |
Mentions in press and media 1
Date | Title | Description |
01.04.2022 | Zhongze Therapeutics Announces Successful Completion Of The First-In-Human Dose Escalation Study of ZZ6398 in Healthy Volunteers | SHANGHAI, April 1, 2022 /PRNewswire/ -- Zhongze Therapeutics, a clinical stage biotech company focused on the discovery, development and commercialization of innovative and transformative therapies for both psychiatric and neurological diso... |